Anthony Rosenberg
CIK: 0001466175
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CGEM
Cullinan Therapeutics, Inc.
Director
Discretionary Trading P&L
Holdings
About Rosenberg Anthony
Rosenberg Anthony (SEC CIK 0001466175) files insider reports with the SEC as Director of Cullinan Therapeutics, Inc. (CGEM).
Signal8 holds 2 ownership filings by Rosenberg Anthony, all Form 4s, filed between Jun 16, 2025 and Jun 18, 2026. Those filings report 2 transactions, from Jun 12, 2025 to Jun 16, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Rosenberg Anthony's filings is in CAMBRIDGE, MA.
Recent filings by Rosenberg Anthony
Other insiders filing for Cullinan Therapeutics, Inc. (CGEM)
- Michaelson Jennifer, Chief Scientific Officer
- SUMER JACQUELYN L, Chief Legal Officer
- Fenton Mary Kay, Chief Financial Officer
- Meek David D., Director
- Webster Stephen W, Director
- Allen Andrew R, Director